Ambulatory Medication Safety Events in High-risk Patients With Diabetes Before and After a COVID-19 Clinic Slowdown
There was a small increase in potential adverse medication events among a cohort of high-risk patients during the COVID-19 pandemic. The most common ADE was hypoglycemia associated with insulin.
Authors
- Samantha I. Pitts (ORCID: https://orcid.org/0000-0002-7345-7525)
- Somer Blair (ORCID: https://orcid.org/0000-0001-9739-2730)
- Zachary N. Hendrix
- Kimberly G. Fulda (ORCID: https://orcid.org/0000-0002-5096-2983)
- Richard A. Young (ORCID: https://orcid.org/0000-0002-2766-5737)
- Yan Xiao (ORCID: https://orcid.org/0000-0003-2805-0619)
- Anna Espinoza (ORCID: https://orcid.org/0000-0002-6689-8656)
- Kari Teigen
- Ayşe P. Gürses (ORCID: https://orcid.org/0000-0001-7422-6852)
- David Li (ORCID: https://orcid.org/0000-0002-8921-5168)
Institutions
- University of North Texas (US)
- Johns Hopkins University (US)
- University of North Texas Health Science Center (US)
- The University of Texas at Arlington (US)
- Johns Hopkins Medicine (US)
- JPS Health Network (US)
Publication Details
- Journal
- Journal of Patient Safety
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1097/pts.0000000000001352
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00